|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07K 16/28 | (2006.01) |
| A61K 31/573 | (2006.01) | ||
| A61K 39/00 | (2006.01) |
| (11) | Number of the document | 3844189 |
| (13) | Kind of document | T |
| (96) | European patent application number | 19782800.7 |
| Date of filing the European patent application | 2019-08-30 | |
| (97) | Date of publication of the European application | 2021-07-07 |
| (45) | Date of publication and mention of the grant of the patent | 2025-01-22 |
| (46) | Date of publication of the claims translation | 2025-02-25 |
| (86) | Number | PCT/US2019/049027 |
| Date | 2019-08-30 |
| (87) | Number | WO 2020/047389 |
| Date | 2020-03-05 |
| (30) | Number | Date | Country code |
| 201862726137 P | 2018-08-31 | US | |
| 201862774019 P | 2018-11-30 | US | |
| 201962861100 P | 2019-06-13 | US |
| (72) |
BROWNSTEIN, Carrie , US
LOWY, Israel , US
ADRIAENS, Lieve Lucille , US
|
| (73) |
Regeneron Pharmaceuticals, Inc. ,
777 Old Saw Mill River Road, Tarrytown, NY 10591,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | CD3/CD20 bispecifinių antikūnų dozavimo strategija, mažinanti citokinų išsiskyrimo sindromą |
| DOSING STRATEGY THAT MITIGATES CYTOKINE RELEASE SYNDROME FOR CD3/CD20 BISPECIFIC ANTIBODIES |
| Payment date | Validity (years) | Amount | |
| 2025-07-23 | 7 | 162.00 EUR |
| 2026-08-30 |